Status:

UNKNOWN

CT and MRI in Prediction of Response in Patients With Gastric Cancer Following Neoadjuvant Chemotherapy and/or Immunotherapy

Lead Sponsor:

The First Hospital of Jilin University

Conditions:

Gastric Cancer

Magnetic Resonance Imaging

Eligibility:

All Genders

18-80 years

Brief Summary

This is a prospective and observational clinical study for seeking out a better way to predict the pathologic complete response (pCR) in patients with advanced gastric cancer (AGC) based on the post-n...

Detailed Description

With the gradual development of neoadjuvant immunotherapy and/or chemotherapy in the clinic, the pCR has become more and more accessible in the AGC. Preoperative accurate prediction of pCR is of great...

Eligibility Criteria

Inclusion

  • Age 18 Years to 80 Years
  • Consecutive patients with preoperative pathologically confirmed AGC by endoscopy and preoperative imaging data (CT/MRI) were included.
  • Clinical staging Ⅱ-Ⅲ according to the UICC/AJCC 8th guideline for gastric cancer without distant metastasis.
  • Suitable for pre-operative chemotherapy, immunotherapy and surgical resection
  • No contraindications for CT/MRI examination.
  • Eastern Cooperative Oncology Group (ECOG) performance status 0-2.
  • The patients participate in this study with informed consent.

Exclusion

  • Patients with a history of previous chemotherapy or immunotherapy.
  • The patients couldn't perform MSCT or MR scanning or artefacts affect the evaluation.
  • The patients are extremely anxious and uncooperative about surgery or neoadjuvant therapy.
  • The patients refuse to participate in the project.
  • Pregnancy, lactation or inadequate contraception
  • Pacemaker or implanted defibrillator
  • Patients with a history of psychological illness or condition such as to interfere with the patient's ability to understand requirements of the study.
  • Other situations considered by investigators, which not meet the inclusion criteria.

Key Trial Info

Start Date :

June 1 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 1 2023

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT04913896

Start Date

June 1 2021

End Date

June 1 2023

Last Update

June 4 2021

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

CT and MRI in Prediction of Response in Patients With Gastric Cancer Following Neoadjuvant Chemotherapy and/or Immunotherapy | DecenTrialz